LataMed AI Corp. (OTC: LMED), a healthcare technology company focused on digital health and artificial intelligence solutions for Latin America, announced on July 31, 2026, that it has entered into an agreement with the Venezuelan Institute for Scientific Research (IVIC) to develop a digital platform module. This module aims to provide authorized business and institutional users with streamlined access to laboratory and scientific services, potentially transforming how these services are requested, managed, and delivered in the region.
Under the agreement, LataMed AI's Venezuelan subsidiary, LATAMEDAI VE, and IVIC will collaborate on the design, development, testing, and implementation of a digital interface. This interface will allow authorized users to request available laboratory services, schedule appointments, monitor the status of submitted requests, access approved reports and documentation, and complete authorized payment-related processes. The proposed module is intended to create a centralized digital workflow for organizations in sectors such as healthcare, pharmaceuticals, food production, agriculture, and related industries.
The specific services to be made available through the platform will be determined by IVIC, with implementation adhering to technical, operational, security, and legal requirements established by both parties. LataMed AI will work alongside IVIC to define functional requirements, user-access procedures, data architecture, payment workflows, document-management capabilities, and a phased testing and implementation process. The parties will also establish procedures for handling, transmitting, storing, and accessing laboratory-related information securely.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated, "This agreement represents an opportunity to apply our technology to an important area of scientific and enterprise service delivery. Our objective is to work with IVIC to develop a responsible digital framework that makes it easier for authorized users to request services, manage appointments, monitor processes, and access approved information through a centralized platform."
The initiative marks a strategic expansion for LataMed AI beyond its patient-facing telemedicine ecosystem. Management believes this module could demonstrate how its technology can support institutional and enterprise workflows involving healthcare, scientific services, laboratory coordination, and digital documentation. This aligns with the company's broader strategy of developing digital infrastructure that connects patients, healthcare professionals, pharmacies, insurers, payment providers, wellness organizations, institutions, and other ecosystem participants.
If successfully implemented, the module could potentially be adapted for other institutional and enterprise service environments in Venezuela and elsewhere in Latin America. However, any future expansion would be subject to separate agreements, technical readiness, regulatory requirements, and the needs of participating institutions. The agreement establishes the framework for development and evaluation but does not guarantee a specific implementation date, user adoption level, service volume, revenue, profitability, or expansion.
LataMed AI will provide further updates as development, testing, and implementation progress. The company continues to focus on building digital health infrastructure and AI-supported medical solutions for Latin America, including platforms like CardioAI, PulmoAI, and NeuroAI, which are designed to assist healthcare professionals in evaluating and managing cardiovascular, pulmonary, and neurological health information. These platforms remain subject to ongoing development and regulatory approval.
This partnership with IVIC represents a significant step forward in LataMed AI's mission to enhance access to critical services through technology, potentially setting a precedent for digital transformation in the scientific and laboratory sector across the region.
